The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Pearlman Andrew since 2012.
The trader's CIK number is 1516544.
At the time of the last reporting, Pearlman Andrew was the President and CEO of Aevi Genomic Medicine, Llc. (stock ticker symbol CERC).
Also see all insider trading activities at Aevi Genomic Medicine, Llc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | MDGN | 0 | $0 | 136,168 | $976,381 | 136,168 | $380,267 |
| 2012 | MDGN | 0 | $0 | 34,623 | $365,040 | 91,403 | $671,812 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-02-12 | MDGN | Sale | 11,168 | 9.00 | 100,512 |
| 2014-02-12 | MDGN | Option Ex | 11,168 | 3.14 | 35,067 |
| 2014-02-04 | MDGN | Option Ex | 20,000 | 2.81 | 56,300 |
| 2014-02-04 | MDGN | Sale | 20,000 | 8.00 | 160,000 |
| 2014-01-29 | MDGN | Option Ex | 500 | 3.14 | 1,570 |
| 2014-01-30 | MDGN | Option Ex | 24,500 | 3.14 | 76,930 |
| 2014-01-29 | MDGN | Sale | 500 | 7.50 | 3,750 |
| 2014-01-30 | MDGN | Sale | 24,500 | 7.50 | 183,750 |
| 2014-01-08 | MDGN | Option Ex | 45,534 | 2.49 | 113,379 |
| 2014-01-09 | MDGN | Option Ex | 34,466 | 2.81 | 97,021 |
| 2014-01-08 | MDGN | Sale | 45,534 | 6.54 | 297,792 |
| 2014-01-09 | MDGN | Sale | 34,466 | 6.69 | 230,577 |
| 2012-09-18 | MDGN | Sale | 5,000 | 10.24 | 51,200 |
| 2012-09-17 | MDGN | Sale | 6,000 | 10.29 | 61,739 |
| 2012-09-13 | MDGN | Sale | 19,623 | 10.66 | 209,181 |
| 2012-09-14 | MDGN | Sale | 4,000 | 10.73 | 42,920 |
| 2012-09-11 | MDGN | Option Ex | 91,403 | 7.35 | 671,812 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pearlman Andrew (President and CEO of Aevi Genomic Medicine, Llc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.